BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15965446)

  • 1. Photopheresis does not improve survival in Sézary syndrome patients with bone marrow involvement.
    de Misa RF; Harto A; Azaña JM; Belmar P; Díez E; Ledo A
    J Am Acad Dermatol; 2005 Jul; 53(1):171-2. PubMed ID: 15965446
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.
    Arulogun S; Prince HM; Gambell P; Lade S; Ryan G; Eaton E; McCormack C
    J Am Acad Dermatol; 2008 Oct; 59(4):589-95. PubMed ID: 18656282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome.
    Gao C; McCormack C; van der Weyden C; Goh MS; Campbell BA; Twigger R; Buelens O; Harrison SJ; Khoo C; Lade S; Prince HM
    Blood; 2019 Oct; 134(16):1346-1350. PubMed ID: 31467061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis in Sézary syndrome.
    Russell-Jones R; Fraser-Andrews E; Spittle M; Whittaker S
    Lancet; 1997 Sep; 350(9081):886. PubMed ID: 9310623
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous tumor cell load correlates with survival in patients with Sézary syndrome.
    Booken N; Nicolay JP; Weiss C; Klemke CD
    J Dtsch Dermatol Ges; 2013 Jan; 11(1):67-79. PubMed ID: 23167557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sézary syndrome: a summary.
    Bouwhuis S; Davis MD
    Dermatol Nurs; 2001 Jun; 13(3):205-7, 230. PubMed ID: 11917454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced extracorporeal photopheresis (forced-ECP) in Sézary syndrome.
    Kreuter A; Gambichler T; Hoffmann A; von Kobyletzki G; Altmeyer P; Hoffmann K
    Int J Dermatol; 2001 Jul; 40(7):476-8. PubMed ID: 11679011
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinal toxic reactions following photopheresis.
    Vagace JM; Gervasini G; Morais F; Benitez J; Alonso N; de Argila D; Arranz I; Bajo R
    Arch Dermatol; 2007 May; 143(5):622-5. PubMed ID: 17515512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis.
    Behle V; von Braunmühl T; Sayehli C; Gesierich A; Goebeler M; Geissinger E; Wobser M
    Acta Derm Venereol; 2017 Aug; 97(8):973-975. PubMed ID: 28512672
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sézary syndrome treated with extracorporeal photopheresis: Report of one case].
    Molgó M; Jaque A; Vial V; Ocqueteau M; Pereira J; Chang M; González S
    Rev Med Chil; 2015 Nov; 143(11):1449-58. PubMed ID: 26757870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photopheresis and the red man syndrome.
    Knobler R
    Dermatology; 1995; 190(2):97-8. PubMed ID: 7727848
    [No Abstract]   [Full Text] [Related]  

  • 13. Photopheresis in the red man or pre-Sézary syndrome.
    Zachariae H; Bjerring P; Brodthagen U; Søgaard H
    Dermatology; 1995; 190(2):132-5. PubMed ID: 7727834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Sézary syndrome with extracorporeal photochemotherapy.
    Smith NP; Mountford L; Ng Y; Hamblin A; Mitchell D; Spittle MF; Whittaker SJ
    Transfus Sci; 1994 Dec; 15(4):439-41. PubMed ID: 10155562
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of cutaneous T-cell lymphoma: The future is here.
    Wood GS
    J Am Acad Dermatol; 2001 Aug; 45(2):317. PubMed ID: 11464201
    [No Abstract]   [Full Text] [Related]  

  • 16. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of photopheresis in Sézary syndrome.
    Stevens SR; Bowen GM; Duvic M; King LE; Knobler R; Lim HW; Margolis D; Parry EJ; Rook AH; Stricklin GP; Suchin KR; Tharp MD; Vonderheid E; Zic JA
    Arch Dermatol; 1999 Aug; 135(8):995-7. PubMed ID: 10456362
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dermatology and extracorporeal photochemotherapy 10 years later].
    Cribier B
    Ann Dermatol Venereol; 1999; 126(8-9):576-9. PubMed ID: 10530342
    [No Abstract]   [Full Text] [Related]  

  • 19. Sézary syndrome.
    Davis MD; Alonsollamazares J; McEvoy MT
    Eur J Dermatol; 2007; 17(1):96. PubMed ID: 17324842
    [No Abstract]   [Full Text] [Related]  

  • 20. Sezary syndrome: a case study of cutaneous T-cell lymphoma.
    Crandon S; Yancey MA
    Clin J Oncol Nurs; 2009 Apr; 13(2):157-9. PubMed ID: 19349262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.